References
Aposhian HV (1983) DMSA and DMPS-water soluble antidotes for heavy metal poisoning. Annu Rev Pharmacol Toxicol 23: 193–215
Aposhian HV, Aposhian MM (1990) meso-2,3-Dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent. Annu Rev Pharmacol Toxicol 30: 279–306
Baxley MN, Hood RD, Vedel GC, Harrison WP, Szczech GM (1981) Prenatal toxicity of orally administered sodium arsenite in mice. Bull Environ Contam Toxicol 26: 749–756
Beaudoin AR (1974) Teratogenicity of sodium arsenate in rats. Teratology 10: 153–158
Chaineau E, Binet S, Pol D, Chatellier G, Meininger V (1990) Embryotoxic effects of sodium arsenite and sodium arsenate on mouse embryos in culture. Teratology 41: 105–112
Domingo JL, Paternain JL, Llobet JM, Corbella J (1988) Developmental toxicity of subcutaneously administered mesodimercaptosuccinic acid in mice. Fundam Appl Toxicol 11: 715–722
Ferm VH, Carpenter SJ (1968) Malformations induced by sodium arsenate. J Reprod Fertil 17: 199–201
Gerber GB, Maes J, Eykens B (1982) Transfer of antimony and arsenic to the developing organism. Arch Toxicol 49: 159–168
Goebel HH, Schmidt PF, Bohl J, Tetteriborn B, Krämer G, Gutmann L (1990) Polyneuropathy due to arsenic intoxication: biopsy studies. J Neuropathol Exp Neurol 49: 137–149
Graziano JH (1986) Role of 2,3-dimercaptosuccinic acid in the treatment of heavy metal poisoning. Med Toxicol 1: 155–162
Hood RD, Bishop SL (1972) Teratogenic effects of sodium arsenate in mice. Arch Environ Health 24: 62–65
Hood RD, Pike CT (1972) BAL alleviation of arsenate-induced teratogenesis in mice. Teratology 6: 235–238
Hood RD, Thacker GT, Patterson BL (1977) Effects in the mouse and rat of prenatal exposure to arsenic. Environ Health Perspect 19: 219–222
Hood RD, Thacker GT, Patterson BL, Szczech GM (1978) Prenatal effects of oral versus intraperitoneal sodium arsenate in mice. J Environ Pathol Toxicol 1: 857–864
Hood RD, Vedel GC (1984) Evaluation of the effect of BAL (2,3-dimercaptopropanol) on arsenite-induced teratogenesis in mice. Toxicol Appl Pharmacol 73: 1–7
Hood RD, Vedel GC, Zaworotko MJ, Tatum FM, Meeks RG (1987) Distribution, metabolism and fetal uptake of pentavalent arsenic in pregnant mice following oral or intraperitoneal administration. Teratology 35: 19–25
IARC (1980) Carcinogenesis of arsenic and arsenic compounds. IARC Monogr Evalu Carcinog Risks Hum 23: 37–141
Kreppel H, Reichl FX, Szinicz L, Fichtl B, Forth W (1990) Efficacy of various dithiol compounds in acute As2O3 poisoning in mice. Arch Toxicol 64: 387–392
Lindgren A, Danielsson BRG, Dencker L, Vahter M (1984) Embryotoxicity of arsenite and arsenate: distribution in pregnant mice and monkeys and effects on embryonic cell in vitro. Acta Pharmacol Toxicol 54: 311–320
Morrissey RE, Mottet NK (1983) Arsenic-induced exencephaly in the mouse and associated lesions during neurulation. Teratology 28: 399–411
Neiger RD, Osweiler GD (1989) Effect of subacute low level dietary sodium arsenite on dogs. Fundam Appl Toxicol 13: 439–451
Willhite CC (1981) Arsenic-induced axial skeletal (disraphic) disorders. Exp Molec Pathol 34: 145–158
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bosque, M.A., Domingo, J.L., Llobet, J.M. et al. Effects of meso-2,3-dimercaptosuccinic acid (DMSA) on the teratogenicity of sodium arsenate in mice. Bull. Environ. Contam. Toxicol. 47, 682–688 (1991). https://doi.org/10.1007/BF01701134
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01701134